Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964–2003 followed up until the end of 2006

References

• Kvale R, Auvinen A, Adami HO, Klint A, Hernes E, Moller B, . Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 2007;99:1881–7.
   PubMed Web of Science ®Google Scholar
• Helgesen F, Holmberg L, Johansson JE, Bergström R, Adami HO. Trends in prostate cancer survival in Sweden, 1960 through 1988: Evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst 1996;88:1216–21.
   PubMedGoogle Scholar
• Engholm G, Ferlay J, Christensen N, Bray F, Klint Å, Ólafsdóttir E, . (2008) NORDCAN: Cancer incidence, mortality and prevalence in the Nordic countries, Version 3.3. http://www.ancr.nu. Association of Nordic Cancer Registries, Danish Cancer Society.
   Google Scholar
• Engeland A, Haldorsen T, Dickman PW, Hakulinen T, Möller TR, Storm HH, . Relative survival of cancer patients–a comparison between Denmark and the other Nordic countries. Acta Oncol 1998;37:49–59.
   PubMed Web of Science ®Google Scholar
• Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, . Recent cancer survival in Europe: A 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007;8:784–96.
   PubMed Web of Science ®Google Scholar
• Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Møller H. Trends in testicular cancer incidence and mortality in 22 European countries: Continuing increases in incidence and declines in mortality. Int J Cancer 2006;118: 3099–111.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Devesa SS, McGlynn KA, Møller H. Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol 2006; 3:532–43.
   PubMedGoogle Scholar
• Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, . Cancer incidence in five continents Vol. IX (IARC Scientific Publication No 160). Lyon: IARC; 2007.
   Google Scholar
• Einhorn LH, Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1977;87: 293–8.
   PubMed Web of Science ®Google Scholar
• Peckham MJ. An appraisal of the role of radiation therapy in the management of nonseminomatous germ-cell tumors of the testis in the era of effective chemotherapy. Cancer Treat Rep 1979;63:1653–8.
   PubMedGoogle Scholar
• Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 2009;20:449–57.
   PubMed Web of Science ®Google Scholar
• Maiche AG. Epidemiological aspects of cancer of the penis in Finland. Eur J Cancer Prev 1992;1:153–8.
   PubMedGoogle Scholar
• Mistry T, Jones RW, Dannatt E, Prasad KK, Stockdale AD. A 10-year retrospective audit of penile cancer management in the UK. BJU Int 2007;100:1277–81.
   PubMedGoogle Scholar
• Kvarstein B, Fossa SD, Harvei S. [Diagnosis and treatment of penile cancer]. Tidsskr Nor Laegeforen 2002;122: 1194–7.
   PubMedGoogle Scholar
• Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Material and methods. Acta Oncol.
   Google Scholar
• Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307–16.
   PubMed Web of Science ®Google Scholar
• Tretli S, Engeland A, Haldorsen T, Hakulinen T, Hörte LG, Luostarinen T, . Prostate cancer–look to Denmark? J Natl Cancer Inst 1996;88:128.
   PubMedGoogle Scholar
• Draisma G, Boer R, Otto SJ, van der Cruijsen IVV, I, Damhuis RA, Schroder FH, . Lead times and overdetection due to prostate-specific antigen screening: Estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003;95:868–78.
   PubMed Web of Science ®Google Scholar
• Jonsson PM, Danneskiold-Samsøe B, Heggestad T, Iversen P, Leisti S. Management of early prostatic cancer in the Nordic countries: Variations in clinical policies and physicians’ attitudes toward radical treatment options. Int J Technol Assess Health Care 1995;11:66–78.
   PubMedGoogle Scholar
• Brasso K, Friis S, Juel K, Jørgensen T, Iversen P. [Morbidity among patients with clinically localized prostatic cancer. A registry-based case-control study]. Ugeskr Laeger 2001;163: 5673–6.
   PubMedGoogle Scholar
• Rørth M. [Cis-diaminodichloroplatinum (Cis-platin). A new cytostatic of special importance in the treatment of testicular cancer]. Ugeskr Laeger 1980;142:2713–6.
   PubMedGoogle Scholar
• Oldenburg J, Lehne G, Fossa SD. [Testicular cancer]. Tidsskr Nor Laegeforen 2008;128:457–60.
   PubMedGoogle Scholar
• Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, . European consensus on diagnosis and treatment of germ cell cancer: A report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004;15:1377–99.
   PubMed Web of Science ®Google Scholar
• Power DA, Brown RS, Brock CS, Payne HA, Majeed A, Babb P. Trends in testicular carcinoma in England and Wales, 1971–99. BJU Int 2001;87:361–5.
   PubMed Web of Science ®Google Scholar
• Andriole GL, Crawford ED, Grubb RL, III, Buys SS, Chia D, Church TR, . Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360:1310–9.
   PubMed Web of Science ®Google Scholar
• Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, . Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320–8.
   PubMed Web of Science ®Google Scholar
• Roobol MJ, Kerkhof M, Schroder FH, Cuzick J, Sasieni P, Hakama M, . Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2009;56:584–91.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick JM, Schulman C, Zlotta AR, Schroder FH. Prostate cancer: A serious disease suitable for prevention. BJU Int 2009;103:864–70.
   PubMed Web of Science ®Google Scholar